Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Preclinical Efficacy of Daratumumab in T Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Karen Bride, MD/PhD |
Young Investigator Grants |
2017 |
New York |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Targeted Hyperactivation of PI3K/AKT in B-cell malignancies |
Dana-Farber Cancer Institute / Vishal Khairnar, PhD |
Young Investigator Grants |
2019 |
Massachusetts |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |
Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells |
Stanford University / Hon-Kit Wong |
Young Investigator Grants |
2010 |
California |
Elucidating the Role of Human FAN1 Nuclease in DNA Crosslink Repair |
Yale School of Medicine / Timsi Rao, PhD |
Young Investigator Grants |
2016 |
Connecticut |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells |
Stanford University / Ramin Dubey, PhD |
Young Investigator Grants |
2015 |
California |